Thyroid stimulating hormone (TSH) was measured in a sample of 4,403 women,
aged 45-70 years in 11 Centers for health screening, to define the interest
of this biological indicator for screening subclinical hypothyroidism. The
aim of this work was to describe clinical signs, symptoms and medical hist
ory linked to TSH variations, to estimate the distribution of this hormone
in a general population and reference limits in a selected subgroup.
All the participating laboratories used the same third-generation immunoass
ay on fresh samples. In the general sample population age mean: 55.2 +/- 6.
9 yrs), 1.1 % presented hyperthyroidism (TSH < 0.3 mU/l) and 0.4 % had hypo
thyroidism (TSH > 12 mU/l). In the sub-sample of 151 women (3.4 %) with TSH
between 4-12 mU/l, 131 had subclinical hypothyroidism (FT4 > 8 ngl). The T
SH mean was significantly lower (- 10 to - 23 %) in women presenting a nodu
lar goiter. inversely, TSH was higher in women with muscle cramps, asthenia
, recent weight gain, morning eyelid edema and abnormal electrocardiogram.
The reference limits for percentiles 2.5 and 97.5 were 0.43 and 3.71 mU/l o
n 1,348 subjects after excluding women having one of these symptoms or taki
ng any drug treatment.